|
|
Volumn 47, Issue 9, 2008, Pages 980-981
|
|
Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIODARONE;
CYCLOSPORIN;
ETANERCEPT;
SEVELAMER;
WARFARIN;
ABSENCE OF SIDE EFFECTS;
AGED;
CASE REPORT;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
HEART ATRIUM FIBRILLATION;
HEMODIALYSIS PATIENT;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
KIDNEY FAILURE;
KIDNEY POLYCYSTIC DISEASE;
LETTER;
LIVER FUNCTION TEST;
MALE;
PHOTOTHERAPY;
PSORIASIS VULGARIS;
QUALITY OF LIFE;
RELAPSE;
SIDE EFFECT;
SINGLE DRUG DOSE;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT REFUSAL;
ULTRAVIOLET B RADIATION;
AGED;
CYCLOSPORINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE;
FOLLOW-UP STUDIES;
HEPATITIS C;
HUMANS;
IMMUNOGLOBULIN G;
INJECTIONS, SUBCUTANEOUS;
KIDNEY FAILURE, CHRONIC;
LIVER FUNCTION TESTS;
MALE;
POLYCYSTIC KIDNEY DISEASES;
PSORIASIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
RENAL DIALYSIS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 50149093269
PISSN: 00119059
EISSN: 13654632
Source Type: Journal
DOI: 10.1111/j.1365-4632.2008.03619.x Document Type: Letter |
|
Times cited : (20)
|
|
References (0)
|
